Drug Shortage Report for MYLAN-BUPRENORPHINE/NALOXONE

Last updated on 2019-09-18 History
Report ID 7392
Drug Identification Number 02408090
Brand name MYLAN-BUPRENORPHINE/NALOXONE
Common or Proper name BUPRENORPHINE/NALOXONE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) BUPRENORPHINE NALOXONE
Strength(s) 2MG 0.5MG
Dosage form(s) TABLET
Route of administration SUBLINGUAL
Packaging size 100BT
ATC code N07BC
ATC description DRUGS USED IN ADDICTIVE DISORDERS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-03
Actual start date 2018-06-26
Estimated end date Unknown
Actual end date 2019-09-17
Shortage status Resolved
Updated date 2019-09-18
Company comments discontinued in ID 94044. Last lot 3085355 exp 2019-05-31
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v103 2018-03-01 English Compare
v102 2018-02-27 French Compare
v101 2018-02-27 English Compare
v100 2018-02-24 English Compare
v99 2018-02-23 French Compare
v98 2018-02-23 English Compare
v97 2018-02-21 English Compare
v96 2018-02-16 French Compare
v95 2018-02-16 English Compare
v94 2018-02-15 English Compare
v93 2018-02-12 French Compare
v92 2018-02-12 English Compare
v91 2018-02-09 French Compare
v90 2018-02-09 English Compare
v89 2018-02-08 French Compare
v88 2018-02-08 English Compare
v87 2018-02-08 English Compare
v86 2018-02-05 French Compare
v85 2018-02-05 English Compare
v84 2018-02-02 French Compare

Showing 41 to 60 of 143